Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF - September 02.01.2026 MSEP.LN IE0009DRFET8 150,002.00 USD 4,053,267.45 27.021  ...

NEW YORK--(BUSINESS WIRE)--  5th January, 2026 CRH plc Transaction in Own Shares CRH plc (“CRH”) announces that on 2nd January 2026 it acquired the following number of its ordinary shares (the “ordinary shares”) in the United States through CRH’s broker Santander US Capital Markets LLC. The ordinary shares acquired (by way of redemption) will be cancelled. Aggregate number of ordinary shares acquired Daily volume weighted average price paid Daily highest price paid per share Daily lowest price...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Rising Dividend Achievers UCITS ETF 02.01.2026 RDVY LN IE000K5F6EL4 525,002.00 USD 11,672,606.26 22.234  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - June 02.01.2026 QJUN.LN IE000HFBJ0U0 3,400,002.00 USD 73,310,857.79 21.562  ...

CHICAGO--(BUSINESS WIRE)--Groupe Acrelec, leader mondial des bornes de commande et des solutions digitales pour les enseignes de restauration rapide (QSR) et de retail, annonce aujourd’hui une transition majeure au sein de son équipe dirigeante, alors que l’entreprise ambitionne d’accélérer sa croissance mondiale. Après avoir guidé Acrelec depuis ses débuts en tant que start-up jusqu’à sa position actuelle de leader mondial dans les technologies, Jacques Mangeot, cofondateur, président et PDG,...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: River Global Investors LLP 213800HIGHFCAY9K8Z97 (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and bene...

BASINGSTOKE, England--(BUSINESS WIRE)--Glory Global Solutions has today announced a major change in executive leadership at its subsidiary, Acrelec, as the company prepares to drive accelerated growth on a global scale. After guiding Acrelec from its origins as a start-up to its present position as a global technology leader, co-founder, President and CEO Jacques Mangeot has stepped down from his roles and left the business. The company expresses its deep appreciation for Jacques’ vision, leade...

INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. gab heute bekannt, dass das Unternehmen mit der direkten Vermarktung von BYOOVIZ®, einem Biosimilar zu Lucentis1 (Ranibizumab), in Europa begonnen hat. Samsung Bioepis hat daran gearbeitet, eine nahtlose Übertragung der Vermarktungsrechte von Biogen zurück an Samsung Bioepis sicherzustellen, und BYOOVIZ wird nun in mehreren europäischen Ländern als Marke von Samsung Bioepis erhältlich sein. „Dies ist ein wichtiger Meilenstein für Samsun...

INCHEON, Corea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. acaba de anunciar que la empresa ha iniciado la comercialización directa de BYOOVIZ®, un biosimilar de Lucentis1 (ranibizumab) en Europa. Samsung Bioepis ha venido trabajando para garantizar una fluida transferencia de los derechos comerciales de Biogen de vuelta a Samsung Bioepis, y BYOOVIZ estará ahora disponible como marca de Samsung Bioepis en varios países europeos. El comunicado en el idioma original es la versión oficial y autori...

INCHEON, Corea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. oggi ha annunciato che l'azienda ha avviato la commercializzazione diretta di BYOOVIZ®, un biosimilare di Lucentis1 (ranibizumab), in Europa. Samsung Bioepis si è impegnata per garantire il trasferimento continuo dei diritti commerciali da Biogen all'originaria Samsung Bioepis, rendendo BYOOVIZ disponibile come marchio Samsung Bioepis in vari Paesi europei. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la...